Abstract: Methods for producing recombinant cell populations are disclosed. The disclosed methods may be used to produce therapeutic polyclonal proteins.
Type:
Grant
Filed:
September 26, 2013
Date of Patent:
September 20, 2016
Assignee:
Excelimmune Liquidating Trust
Inventors:
Vincent W. Coljee, Gwendolyn M. Wilmes, Stuart Hicks, Kimberly L. Carey, Elizabeth R. Reczek